Varaico: Literature-Extracted Genetic Variants

Gene:TYMS
Variant:p.M1I
Back to variants list

TYMS

NM_001071.4:p.M1I

Associated Papers

DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients.

Khalij Y et al.

Journal of Chemotherapy (florence, Italy), 2023

Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.

Dawidowska M et al.

Scientific Reports, 2016

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.

Thomas F et al.

British Journal of Cancer, 2011

Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.

Thomas F et al.

Pharmacogenomics, 2010

Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?

Shahrokni A et al.

Clinical Colorectal Cancer, 2009

Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.

Shahrokni A et al.

Jop : Journal of the Pancreas, 2009

Differential stability of thymidylate synthase 3'-untranslated region polymorphic variants regulated by AUF1.

Pullmann R et al.

The Journal of Biological Chemistry, 2006

Thymidylate synthase pharmacogenetics.

Marsh S

Investigational New Drugs, 2005

Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.

Pastorakova A et al.

Neoplasma, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."